Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update

Hepatitis C virus (HCV) infection is a systemic disease associated with multiple significant extrahepatic manifestations. Emerging studies indicate association between the HCV infection and a higher incidence of major adverse cardiovascular events such as: coronary artery disease, heart failure, str...

Full description

Bibliographic Details
Main Authors: Hrvoje Roguljic, Vjera Nincevic, Kristina Bojanic, Lucija Kuna, Robert Smolic, Aleksandar Vcev, Dragan Primorac, Andrijana Vceva, George Y. Wu, Martina Smolic
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Pharmacology
Subjects:
hepatitis C virus
direct antiviral agents
cardiovascular disease
diabetes mellitus
dyslipidemia
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.678546/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.678546/full

Similar Items